Aplagon

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$7.2M

Aplagon is a biopharmaceutical company developing first-in-class therapeutics for thrombo-inflammatory diseases, focusing on conditions like peripheral arterial occlusive disease and chronic limb threatening ischemia.